Resumo
ENCORE, a randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients stabilized on enzyme replacement therapy: 24-month results
Fecha
2015-02-01Registro en:
Molecular Genetics and Metabolism. San Diego: Academic Press Inc Elsevier Science, v. 114, n. 2, p. S33-S34, 2015.
1096-7192
10.1016/j.ymgme.2014.12.058
WOS:000348973100056
Autor
Cox, Timothy M.
Drelichman, Guillermo I.
Cravo, Renata
Balwani, Manisha
Burrow, Thomas Andrew
Martins, Ana Maria [UNIFESP]
Lukinag, Elena
Rosenbloom, Barry E.
Ross, Leorah H.
Angell, Jennifer
Peterschmitt, M. Judith